Large-scale clinical studies on detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) have shown that quantification of MRD levels is needed for reliable MRD-based risk group classification. Recently, we have shown that 'real-time' quantitative PCR (RQ-PCR) can be applied for this purpose using patient-specific immunoglobulin (Ig) and T cell receptor (TCR) gene rearrangements as PCR targets with TaqMan probes at the position of the junctional region and two germline primers. Now, we tested an alternative approach on 35 immunoglobulin heavy chain (IGH) gene rearrangements, by designing three germline J H TaqMan probes to be used in combination with one of six corresponding germline J H primers and one allele specific oligonucleotide (ASO) primer complementary to the junctional region. In nine cases in which both approaches were compared, at least similar (n = 4) or slightly higher (n = 5) maximal sensitivities were obtained using an ASO primer. The ASO primer approach reached maximal sensitivities of at least 10 −4 in 33 out of 35 IGH rearrangements. The reproducible range for accurate quantification spanned four to five orders of magnitude in 31 out of 35 cases. In 13 out of 35 rearrangements the stringency of PCR conditions had to be increased to remove or diminish background signals; this only concerned the frequently occurring J H 4, J H 5 and J H 6 gene rearrangements. After optimization of the conditions (mainly by increasing the annealing temperature), only occasional aspecific amplification signals were observed at high threshold cycle (C T ) values above 42 cycles and at least six cycles above the C T value of the detection limit. Hence, these rare aspecific signals could be easily discriminated from specific signals. We conclude that the here presented set of three germline J H TaqMan probes and six corresponding germline J H primers can be used to develop patient-specific RQ-PCR assays, which allow accurate and sensitive MRD analysis in almost all IGH gene rearrangements. These results will facilitate standardized RQ-PCR analysis for MRD detection in large clinical studies. Leukemia (2000) 14, 1426-1435.
Introduction
Several prospective clinical 'minimal residual disease' (MRD) studies in childhood acute lymphoblastic leukemia (ALL) have shown that it is important to determine precisely the level of MRD at early remission time points for discrimination between low-and high-risk patients. [1] [2] [3] [4] Information about the kinetics of tumor load reduction has allowed the recognition of three MRD-based risk groups with significant differences in relapse rate. which are present in the vast majority of pediatric and adult ALL patients. 5, 9, 10 The PCR technique has the ability to amplify target DNA up to a plateau, implying that after 35 to 40 cycles it is not possible to define precisely the initial amount of target DNA. Also more quantitative methods, like competitive PCR and limiting dilution are based on post-PCR 'end-point' analysis. [11] [12] [13] [14] [15] These techniques require serial dilutions and the analysis of multiple replicates, which introduce variability and are too difficult and too time-consuming to be performed routinely.
The novel 'real-time' quantitative PCR technology (RQ-PCR) circumvents the above problems, because the PCR product accumulation is monitored throughout the complete PCR process. 16 The method is based on the 5Ј → 3Ј nuclease activity of Taq DNA polymerase and an internal dual-labeled fluorogenic probe with a 5Ј-reporter dye and a 3Ј-quencher dye. 17 During PCR, the 5Ј → 3Ј nuclease activity of Taq DNA polymerase cleaves the hybridized probe and thereby separates the reporter dye from the quencher dye, resulting in emission of a fluorescent signal that increases during each subsequent PCR cycle. The real-time detection of fluorescence intensity generates quantitative data based on the early cycles when the fidelity of PCR amplification is the highest. This quantification can be performed over a large dynamic range of four to five orders of magnitude.
Previously, we have shown that RQ-PCR can be used for the quantification of MRD levels using patient-specific Ig/TCR gene rearrangements as PCR targets with allele-specific oligonucleotide (ASO) probes. 18 All 12 patient-specific ASO probes developed for Ig/TCR gene rearrangements in four precursor-B-ALL were able to detect and to quantify leukemiaderived DNA. Sensitivities of 10 −3 to 10 −5 could be obtained, which were comparable to the dot-blot method but less sensitive than liquid hybridization. Other groups have shown that RQ-PCR can be used for quantification of MRD levels using leukemia-specific chromosome aberrations as PCR targets, ie t(9;22), t(14;18), t(8;21) and t(12;21). [19] [20] [21] [22] [23] Now, we tested an alternative RQ-PCR approach for IGH gene rearrangements, by positioning the TaqMan probe and one of the primers at germline J H segments in combination with an ASO primer complementary to the junctional region. This ASO primer approach theoretically results in more sensitive MRD detection compared to usage of germline primers, because no competition can occur with the amplification of similar rearrangements in normal cells. Furthermore, the design of germline TaqMan probes is more cost-effective, since it would not be necessary to design TaqMan probes per patient but per type of Ig/TCR gene rearrangement. Firstly, we compared the alternative ASO primer approach with our initial ASO probe approach in nine IGH gene rearrangements.
Secondly, we performed RQ-PCR analysis of 35 IGH gene rearrangements using the ASO primer approach.
Materials and methods

Patients and cell samples
Bone marrow (BM) samples were derived from 34 childhood precursor-B-ALL patients at diagnosis. The mononuclear cell (MNC) fractions were isolated by Ficoll-Hypaque (1.077 g/cm 3 ; Pharmacia, Uppsala, Sweden) density gradient centrifugation prior to cryopreservation. The MNC usually contained у90% leukemic blasts as assessed by routine immunophenotyping. Genomic DNA was extracted from MNC with the QIAamp Blood kit (Qiagen, Chatsworth, CA, USA), as described before. 24 Clonality of the B cells was proven by Southern blot analysis of IGH genes in BglII digests with the H24-J H or IGHJ6 probe. 25, 26 Patients included in this study were randomly chosen except for positive selection of at least two different rearrangements for each of the J H gene segments (11 J H 6, eight J H 5, nine J H 4, two J H 3, two J H 2 and three J H 1 gene rearrangements). Five patients (5538, 5627, 5807, 6198 and 6437) showed an oligoclonal IGH gene rearrangement pattern as assessed by Southern blot analysis (Table 1 ). All studied IGH gene rearrangements represented major clones and were representative for rearrangements found in precursor-B-ALL. In one patient (5978) two IGH gene rearrangements were used.
Identification of PCR targets
Complete IGH gene rearrangements were amplified with V Hfamily-specific framework region 1 (FR1) primers VH1/7, VH2, VH3, VH4/6, VH5 and a consensus FR3 in combination with a consensus joining primer JH21. [27] [28] [29] Usually, major PCR bands on ethidium bromide-stained polyacrylamide gels were excised and eluted in 10mM Tris pH 8.0. After a second round PCR with the same primer combination, the PCR product was directly used for the sequence reaction using the Big Dye Terminator Cycle Sequencing Ready Reaction kit and an ABI PRISM 377 Automated Sequencer (PE Biosystems, Foster City, CA, USA). V H , D H and J H gene segments were identified using DNAPLOT software (W Mü ller, H-H Althaus, University of Cologne, Germany) by searching for homology with all known human germline V H , D H and J H sequences obtained from the VBASE directory of human Ig genes (http://www.mrccpe.cam.ac.uk/imt-doc/).
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Design of ASO primers and ASO probes
All primers and probes were designed with the Primer Express version 1.0 software (PE Biosystems) and the OLIGO 6.1 software (Wojciech Rychlik, Molecular Biology Insights, Cascade, CO, USA). In general, TaqMan probes did not have a G at the 5Ј-end, contained more Cs than Gs, and the melting temperature (Tm, nearest neighbour method) was 67 to 70°C, and 8 to 10°C above the Tm of the primers, according to the manufacturer's guidelines. FAM was chosen as reporter dye at the 5Ј-end of the probe and TAMRA as the quencher dye at the 3Ј-end. Oligonucleotides that were likely to form secondary structures were avoided.
ASO's were developed complementary to the V H -D H or D H -J H junctional regions ( Figure 1 , Table 1 ). In contrast to germline oligonucleotides, primer-dimer formation with ⌬G higher than −3.5 kcal/mol, stretches of four or more Gs, and GC-rich 3Ј-ends, could not always be avoided in ASO primers. Amplicon size ranged from 74 to 178 bp. In two cases (5978 and 6264; Table 1 ) shorter ASO primers with a Tm of 53°C were developed to increase specific annealing.
For the ASO probe approach we designed a probe complementary to the junctional region (Table 1) and matching germline V H -and J H -primers (Table 2) . 18 For the ASO primer approach we designed three probes to the germline J H gene segments. Probe T-JH-1.2.4.5 was designed to the J H 1, J H 2, J H 4 and J H 5 gene segments, with one mismatch for J H 2 in the middle of the probe (C instead of T). Probe T-JH3 and probe T-JH6 were designed to the J H 3 and J H 6 gene segments, respectively. Six J H gene segment-specific reverse primers were designed complementary to the intron downstream of each J H gene segment ( Table 2 ). The ASO forward primers were designed at the same strand as the germline J H probes. At least a part of each ASO primer was complementary to the junctional region.
RQ-PCR analysis
For RQ-PCR analysis the TaqMan 1000 Reactions Gold with Buffer A kit (PE Biosystems) was used. Reaction mixtures of 50 l contained the TaqMan buffer A with the ROX dye as passive reference, 5mM MgCl 2 , 200 M each dNTPs, 300 nM primers (ASO primer approach) or 900 nM primers (ASO probe approach), 100 nM probe, 1.25 U AmpliTaq Gold (PE Biosystems), 10% glycerol and 500 ng DNA. The reaction conditions were 10 min 95°C followed by 50 cycles of 15 s 95°C and 1 min 60-69°C. Fluorescence data were collected during the annealing/extension phase of every cycle, using the ABI PRISM 7700 Sequence Detection System containing a 96-well thermal cycler (PE Biosystems). All RQ-PCR experiments were performed in duplicate.
The fluorescence intensity was normalized using the passive reference ROX. A real-time amplification plot was generated using the normalized reporter signal (Rn). The PCR product yield or ⌬Rn was defined as the Rn minus the baseline signal established in the first few cycles of the PCR. The threshold cycle (C T ) was that cycle where PCR product was first detected. The entire RQ-PCR analysis was performed in a closed tube.
To check for the quantity and quality (amplifiability) of DNA, we used RQ-PCR analysis of the albumin gene, as described before. 18 The RQ-PCR results of the albumin gene in the various DNA samples differed less than a factor 2, implying that the amount of DNA per tube and the amplifiability of the DNA samples were very comparable.
PCR target sensitivity
To determine the efficiency of amplification and sensitivity of the PCR target, diagnosis DNA was diluted according to square root 10-fold dilutions into MNC DNA, from 10 −1 down to 3.16 × 10 −6 . To avoid skewed gene rearrangement patterns and to obtain a bulk of the polyclonal control, the normal MNC DNA was isolated from equivalent mixtures of PB-MNC from 10 different healthy donors. The dilution series of diagnosis DNA was subjected to RQ-PCR analysis together with negative controls (H 2 O and MNC). To be able to compare the C T and ⌬Rn values of the different primer/probe combinations, the RQ-PCR data have also been analyzed using a fixed threshold of 0.01. For analyzing the slope and correlation coefficient of each standard curve, automatically set (optimal) thresholds were used.
The reproducible range of a primer/probe combination was defined as that part of the standard curve in which the maximal difference in C T value of the duplicate dilution samples was 1.5 cycles, with a maximal C T value of 40 cycles. In this reproducible range the standard curve should have a correlation coefficient of at least 0.95 for precise quantification.
The maximal sensitivity (sensitivity threshold) of a primer/probe combination was defined as the last dilution of diagnosis DNA in which at least one of the duplicate dilution samples resulted in a positive fluorescent signal with a maximal C T value of 40 cycles. Furthermore, these C T values had Table 2 for sequences).
Table 2
Germline primers and probes used for RQ-PCR analysis to be at least six cycles lower than the C T values found with any aspecific amplification in normal MNC DNA. Theoretically, the maximal sensitivity should be between 10
(approximately 16 copies of target gene) and 10
(approximately 1.6 copies of target gene), based on the assumption that a cell contains 6.25 pg DNA and the fact that we used 0.5 g of DNA per tube and two tubes per test (1 g in total). For all experiments, the specificity of amplification and detection was tested on four control MNC DNA. For some cases, an additional eight or 20 MNC DNA were tested together with the 10 −3 dilution of the diagnosis DNA to check for the amplification efficiency. The C T value did not differ more than one cycle with the original experiments.
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Results
Comparison of ASO probe vs ASO primer
To compare the ASO probe approach using germline V H and J H primers with the ASO primer approach using germline J H probes, we tested nine IGH gene targets (four J H 4, one J H 5 and four J H 6 rearrangements) obtained from precursor-B-ALL samples (Table 3) . For all nine IGH rearrangements, it was possible to develop primer/probe combinations for both approaches, which resulted in successful amplification and real-time detection.
The reproducible ranges of the ASO primer approach were comparable to those of the ASO probe approach; in three cases it was equal for both approaches, in five cases the ASO primer approach resulted in a longer range, and in one case the ASO probe approach resulted in a longer range. The C T values at a fixed threshold of 0.01 had in all cases a range between 20 and 36, except for case 6148 (C T range of [29] [30] [31] [32] [33] [34] [35] [36] [37] . Only twice, in the 10 −5 dilutions of cases 6264 and 6437, was a positive signal measured above 40 cycles (Table 3) . Both positive signals were found using the ASO probe approach in the absence of background signals in four control MNC DNA samples. Hence, we assume that these positive signals represented specific detection.
In all cases except for cases 6148 and 6264, the C T values of the 10 −1 dilution were one to three cycles lower in the ASO primer approach as compared to the ASO probe approach. The maximal sensitivity of the ASO primer approach was in five of the nine cases comparable to those of the ASO probe approach, while in four cases the ASO primer approach was more sensitive, either 3.16-fold (two cases) or 10-fold (two cases). Only in case 6148 the maximal sensitivity (10
) was too low with respect to the theoretical maximum. In all other eight cases a maximal sensitivity of 10 −4 to 3.16 × 10 −6 was reached ( Table 3) .
The ⌬Rn values (yield of generated PCR product) in the reproducible range were lower in all ASO probe cases as compared to ASO primer cases. Moreover, the ASO probe approach showed a reduction of ⌬Rn values in higher dilutions (Figure 2 ). This is probably owing to competition for germline primers during amplification of the patient-specific clonal IGH gene rearrangement and similar rearrangements in normal cells. However, the polyclonal IGH gene rearrangements are not detected by the ASO probe due to a different junctional region. Increase of the primer concentration to 900 nM, to avoid exhaustion of the germline primers in the ASO probe approach did not result in higher ⌬Rn values (data not shown).
During the log phase of an optimal amplification, the The reproducible range of a primer/probe combination was defined as that part of the standard curve in which the maximal difference in C T value of the duplicate dilution samples was 1.5 cycles with a maximal C T of 40 cycles. d The maximal sensitivity of a primer/probe combination was defined as the last dilution of diagnosis DNA in which at least one of the duplicate dilution samples resulted in a positive fluorescent signal, with a C T value of maximal 40 cycles and at least 6 cycles lower than the C T values found for the aspecific amplification for this primer/probe combination in normal MNC DNA. e For all experiments, the specificity of amplification and detection was tested on four control MNC DNA (0.5 g each).
amount of PCR product will duplicate each cycle. In principal, after 3.3 cycles the amount of PCR product will increase 10 times, resulting in a theoretical slope of the standard curve of 3.3. All 18 primer-probe combinations showed slopes between 3.2 and 3.9, indicating good amplification efficiencies ( Table 3 ). The slopes with the ASO primer approach (3.4 ± 0.16) were slightly better than the slopes with the ASO probe approach (3.6 ± 0.22). The correlation coefficients of all 18 standard curves in the reproducible range were excellent (0.96-1.00).
Performance of RQ-PCR analysis using ASO primers in 35 IGH gene rearrangements
Next, we tested whether RQ-PCR analysis with germline J H TaqMan probes in combination with an ASO primer is broadly applicable in precursor-B-ALL. For this purpose we tested a large series of 35 IGH gene rearrangements from 34 patients, including the nine rearrangements described above. Before defining the sensitivity, we first tested in pilot experiments whether the primer/probe combinations were able to amplify and detect the junctional regions in diagnosis DNA using normal MNC DNA as negative control. These tests were carried out under standard conditions. All 35 primer/probe combinations resulted in robust amplification. However in 13 out of 35 cases aspecific amplification and detection of polyclonal IGH gene rearrangements in the control MNC DNA took place, with C T values below 45 (range 35-45). For these cases, the specificity of the RQ-PCR had first to be increased (see below).
All seven combinations for the rarely used J H 1, J H 2 and J H 3 IGH gene rearrangements resulted in sensitive and specific amplification and real-time detection under standard conditions, ie an annealing/extension temperature of 60°C (Table  4 ). The maximal sensitivity ranged between 10 −4 and 3.16 × 10 −6 . The reproducible range for accurate quantification spanned over up to at least four orders of magnitude in all cases (Table 4) In 15 out of 28 primer/probe combinations for the more frequently occurring J H 4, J H 5 and J H 6 IGH gene rearrangements, no aspecific amplification with C T values below 45 cycles was found in control MNC DNA using standard conditions with an annealing/extension temperature of 60°C (Table 4 ). The maximal sensitivity ranged between 10 −4 and 3.16 × 10 . The reproducible range for accurate quantification spanned at least four orders of magnitude in all cases. No positive signals were found with C T values above 38 cycles. All ⌬Rns (1.7 ± 0.4), slopes (3.3 ± 0.1), and correlation coefficients (0.95-1.00) of the standard curves indicated robust amplification and PCR product detection.
In the other 13 primer/probe combinations for the J H 4, J H 5 and J H 6 rearrangements, aspecific amplification of polyclonal IGH gene rearrangements in MNC DNA took place under
Figure 2
Real-time amplification plots of precursor-B-ALL patient 6480. RQ-PCR analysis of the serial dilutions of diagnosis DNA into MNC DNA were performed in duplo via the ASO probe approach (a) and via the ASO primer approach (b). The ASO primer approach resulted in higher ⌬Rn values, a larger reproducible range, and a higher maximal sensitivity than the ASO probe approach (see also standard conditions with an annealing/extension temperature of 60°C, resulting in C T values below 45 (range 35-45). More stringent conditions to avoid this aspecific amplification were necessary. In practice two straightforward possibilities exist. Firstly, by increasing the annealing temperature of the amplification reaction, and secondly by reducing the length of the ASO primer, particularly the part of the primer that is complementary to germline gene segments. For cases 5978 and 6264 shorter ASO primers were developed, both with a Tm of 53°C. For case 6264 optimal annealing with the new primer was achieved at 60°C. In all other cases, we preferred to increase the annealing temperature, because in this way the same ASO primer could be used. The annealing temperature was increased in steps of 2 or 3°C, ranging from 62°C to 69°C, till the aspecific amplification of polyclonal IGH gene rearrangements in control MNC DNA did not reach C T values Leukemia below 45. In the serial dilutions of diagnosis DNA no positive signals were found with C T values above 39, and the positive signals were at least nine cycles lower than the C T values found in control MNC DNA. After optimization, almost all 13 primer/probe combinations showed a maximal sensitivity and a reproducible range for accurate quantification, which was comparable to those of the 22 primer/probe combinations tested under standard conditions. Only for cases 5978 and 6148 a limited sensitivity of 10 −3 was reached ( Table 4) .
Specificity of the primers/probe combinations
For all primer/probe combinations, the specificity of amplification and detection was tested on at least four control MNC DNA. For the ASO probe approach, no positive fluorescent To be able to compare the C T values of the different primer/probe combinations, the RQ-PCR data have been analyzed using a fixed threshold of 0.01. Only for analyzing the slope of each standard curve optimal thresholds have been used. c The reproducible range of a primer/probe combination was defined as that part of the standard curve in which the maximal difference in C T value of the duplicate dilution samples was 1.5 cycles with a maximal C T of 40 cycles. d The maximal sensitivity of a primer/probe combination was defined as the last dilution of diagnosis DNA in which at least one of the duplicate dilution samples resulted in a positive fluorescent signal, with a C T value of maximal 40 cycles and at least 6 cycles lower than the C T values found for the aspecific amplification for this primer/probe combination in normal MNC DNA. e For all experiments, the specificity of amplification and detection was tested on at least four control MNC DNA, which was in some cases extended to 12 (8 samples extra) or 24 (20 samples extra). f ASO-primers F-VH1-5978b and F-VH6-6264b had a Tm of 53°C (nearest neighbour method).
signal was ever found in control MNC DNA samples (Table  3) . For the ASO primer approach under standard conditions, at first instance 13 out of 35 (37%) primer/probe combinations showed fluorescent signals in control MNC DNA, indicating aspecific amplification of normal polyclonal IGH rearrangements. After optimization of the RQ-PCR (mainly by increasing the annealing temperature), only five primer/probe combinations still showed aspecific amplification, but with high C T values above 45.
To test whether the specificity of the ASO primer approach could be reproduced consistently, we tested an additional 20 control MNC DNA samples for three primer/probe combinations (patients 6396, 6437 and 6480) under standard conditions. Also for all 13 primer/probe combinations under the optimized conditions, eight extra control MNC DNA samples were tested in addition to the four control MNC DNA samples tested before. Of the 16 primer/probe combinations tested, incidental aspecific amplification of polyclonal IGH gene rearrangements in MNC DNA was found in 10 cases (Table  4 ). In nine out of 10 this concerned one to three MNC samples positive out of the total of 12 to 24 control samples, but for one case (5579) seven out of 12 samples were positive. In seven cases, positive signals were found after 45 cycles, all at least nine cycles later than the maximal sensitivity of the primer/probe combinations. In three cases (5579, 5902 and 6216) positive signals in MNC DNA had C T values of 42-43 cycles, but still six to eight cycles above that of the maximal sensitivity (Table 4) .
Discussion
In a recent publication we have shown that the RQ-PCR technique using patient-specific Ig/TCR gene rearrangements as PCR targets is a reliable method for the quantification of MRD in precursor-B-ALL. 18 Patient-specific (ASO) TaqMan probes complementary to the junctional region, were combined with two germline primers. In the present study, we show that at least equally sensitive detection and quantification of IGH gene rearrangements can be reached by positioning the TaqMan probe and one of the primers at germline sequences of J H gene segments in combination with one ASO primer. For ASO primer design we used both V H -D H and D H -J H junctional regions, although for MRD studies it may be preferred to use mainly D H -J H junctional regions, in order to prevent falsenegative results due to ongoing IGH gene rearrangements involving pre-existing D H -J H joinings. 5, [33] [34] [35] The sequence variability between the different J H gene segments allowed us to design three different J H TaqMan probes, one specific for J H 3, one specific for J H 6 and one specific for J H 1, J H 2, J H 4 and J H 5 gene segments. To obtain higher specificity, these probes were used in combination with reverse primers that were made specific for each of the six J H gene segments by positioning them at the downstream introns.
First, we compared the alternative ASO primer approach with our initial ASO probe approach for nine IGH gene rearrangements (four J H 4, one J H 5 and four J H 6 rearrangements) obtained from nine randomly chosen precursor-B-ALL. Both approaches resulted in successful amplification and real-time detection for all IGH rearrangements. Specific amplification using the ASO primers resulted for five out of the nine IGH rearrangements in a longer reproducible range for accurate quantification and in higher maximum sensitivities, compared to the results obtained with the ASO probe approach. In the remaining four IGH rearrangements similar results were obtained for both approaches. Representative results of both approaches are given in Figure 2 , which illustrates that a disadvantage of the ASO probe approach was the low plateau level of fluorescent signal (maximum ⌬Rn) at higher dilutions. We assume that this frequent finding was caused by competition for germline primers between patientspecific IGH gene rearrangements and similar polyclonal IGH gene rearrangements in normal cells. In the higher dilutions the maximum ⌬Rn is even so low that it is hard to distinguish between specific signals and background signals. So, followup samples with low MRD levels will just like the higher dilutions also show very low ⌬Rn values and will be difficult to evaluate. This is in contrast to the ASO primer approach, where specific amplification results in high plateau levels, even in the higher dilutions.
The RQ-PCR analysis by the ASO primer approach of 35 IGH gene rearrangements showed robust amplification. The sensitivities obtained were higher (10 −4 -10 −5 ) than previously reported with ASO probes. 18 The improved sensitivity is probably due to the fact that in the ASO primer approach no competition exists for primers between the amplification of the leukemic and normal IGH gene rearrangements. The reproducible range for accurate quantification spanned at least four orders of magnitude in almost all cases (31/35) . In only two out of 35 (6%) was the maximum sensitivity below the theoretical sensitivity threshold of 10 −4 (approximately 16 copies of the target gene). In both patients this was found under extra stringent amplification conditions to avoid aspecific amplification of polyclonal IGH gene rearrangements in MNC DNA. In such patients, it is probably better to use another PCR tarLeukemia get. For example, in patient 5978 another IGH gene rearrangement (V H 3-J H 4) reached a 100-fold higher sensitivity (10 −5 instead of 10 −3 ). The applicability of the ASO primer approach depends on its sensitivity and specificity. Specificity of the primer/probe combinations depends on one patient-specific forward primer. Factors that influence the specificity of RQ-PCR analysis using an ASO primer are: (1) the gene segments used in the V H -D H and D H -J H junctional regions; (2) the size and sequence of the junctional region; (3) and the background of normal cells with comparable gene rearrangements. By positioning the 3Ј-end of the ASO primer at the junctional region, no aspecific amplification was found in 22 out of 35 primer/probe combinations (63%) under standard RQ-PCR conditions. Particularly amplification of the J H 1, J H 2 and J H 3 rearrangements did not result in aspecific background signals, which can probably be explained by the fact that these J H gene segments are rarely used in pediatric and adult peripheral B lymphocytes. [36] [37] [38] [39] This is in contrast to the commonly used J H 4, J H 5 and J H 6 rearrangements, where in 13 out of 28 primer/probe combinations (46%) aspecific amplification was found. In these cases additional stringent conditions were necessary to diminish this aspecific amplification. In virtually all cases, the stringency of amplification was successfully improved by increasing the annealing/extension temperature (up to 69°C). This resulted in specific amplification and did not affect the efficiency of amplification and detection, except for cases 5978 and 6148 as described above. We preferred to increase the annealing temperature instead of shortening the ASO primer, because the former approach is easy to perform and allows the use of the existing ASO primer, thereby saving time and costs.
We evaluated whether positioning of the ASO primer and the lengths of the junctional region were related to the occurrence of aspecific amplification. Although aspecific amplification indeed tended to be absent in the case of IGH rearrangements with high nucleotide insertion in the junctional region, several exceptions were found, such as case 5594 with 20 N-nucleotides in the ASO primer, which needed stringent conditions to remove background signals.
To gain more insight into the characteristics of aspecific amplification, we tested all primer/probe combinations that were at least once positive in MNC-derived DNA in separate RQ-PCR reactions using normal MNC DNA as input. The C T values of 'false-positive' signals were in three out of 16 cases below 45, but always above 42 and at least six to eight cycles above the C T value found at the detection limit of the dilution series. In conclusion, specific amplification could be easily discriminated from incidental aspecific amplification, implying that sensitive quantification of MRD levels is possible.
The germline J H TaqMan probes in combination with J Hspecific reverse primers might also be useful for quantification of IGH gene rearrangements in mature B cell malignancies. Although in most of these cases the presence of somatic hypermutation allow the design of two patient-specific primers, 29 our good results justify screening for the applicability of our set of germline J H TaqMan probes and primers in future studies. In addition, our J H TaqMan probes and primers might also be useful for MRD detection via chromosomal translocations in which J H gene segments are involved, like t(14;18) and t (11;14) .
Our results demonstrate that RQ-PCR analysis of IGH gene rearrangements with one primer at the patient-specific V H -D H or D H -J H junctional region combined with a germline J H Taq-Man probe and a germline primer, is applicable for MRD analysis in precursor-B-ALL. However, not all junctional regions might be suitable for designing a specific ASO primer, particularly in case of a limited insertion of N-nucleotides. In those cases where aspecific amplification still occurs after optimization, it is frequently possible to use another PCR target.
5,9,10 Currently, we are testing the ASO primer approach for other Ig/TCR gene rearrangements suitable for MRD PCR analysis, ie TCRD, TCRG and IGK-Kde. 5, 8 We expect that standardized RQ-PCR analysis for MRD detection in ALL will soon be available for large-scale clinical studies.
